article thumbnail

Recommended Immunization Schedules for 2023

Drug Topics

The updates include new recommendations for COVID-19 and pneumococcal vaccines.

article thumbnail

Slideshow: 2023 Vaccine Approvals

Drug Topics

Vaccine approvals included two immunizations for RSV and a new pentavalent meningococcal shot.

Vaccines 492
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Five Things For Pharmacists To Know About Measles in 2025

IDStewardship

People born before 1957 are considered immune, because the vaccine was given to such a large percentage of that population. The COVID-19 pandemic is credited for disrupting routine measles immunization services in many countries, which is likely contributing to a recent resurgence in cases globally. The recommended dose is 0.5

Vaccines 204
article thumbnail

STAT+: Dreams of cancer vaccines are becoming more real. Here are 9 scientists making it happen 

STAT

But many other modes of immunotherapy for cancer were approved first — checkpoint blockade drugs like Keytruda and engineered immune cell therapies like Yescarta. Cancer vaccines may also be able to help train the immune system to recognize and kill cancers related to viruses like HPV.

Vaccines 144
article thumbnail

2023 ACIP Updates for Immunizations in Adults and Children: What Pharmacists Need to Know

Pharmacy Times

Pharmacists who immunize must ensure their knowledge about routine vaccinations for adults and children is up-to-date by reviewing the changes to the immunization schedule each year.

article thumbnail

Combining new and existing immunity: A 3D approach to killing cancer

pharmaphorum

Combining new and existing immunity: A 3D approach to killing cancer Mike.Hammerton Fri, 08/09/2023 - 08:00 Bookmark this

article thumbnail

CDC’s ACIP Votes in Favor of Universal Recommendation for 2023-2024 Monovalent COVID-19 Vaccines

Pharmacy Times

The CDC emphasized the need for protein-based vaccine options in endorsing a vote by the Advisory Committee on Immunization Practices for the universal recommendation of the 2023-2024 monovalent, XBB containing COVID-19 vaccines.

Vaccines 139